During Medlab Middle East in Dubai, held from June 21 to 24, 2021, CHIL actively engaged with regional stakeholders in laboratory diagnostics under evolving public health conditions. Throughout the four-day event, the company highlighted its latest innovations and explored emerging opportunities, demonstrating agility and commitment to advancing healthcare solutions even amid ongoing uncertainties.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.